These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 24732867)
1. Prucalopride improves bowel function and colonic transit time in patients with chronic constipation: an integrated analysis. Emmanuel A; Cools M; Vandeplassche L; Kerstens R Am J Gastroenterol; 2014 Jun; 109(6):887-94. PubMed ID: 24732867 [TBL] [Abstract][Full Text] [Related]
2. Association between health-related quality of life and symptoms in patients with chronic constipation: an integrated analysis of three phase 3 trials of prucalopride. Tack J; Camilleri M; Dubois D; Vandeplassche L; Joseph A; Kerstens R Neurogastroenterol Motil; 2015 Mar; 27(3):397-405. PubMed ID: 25581251 [TBL] [Abstract][Full Text] [Related]
3. Effect of prucalopride on symptoms of chronic constipation. Tack J; Stanghellini V; Dubois D; Joseph A; Vandeplassche L; Kerstens R Neurogastroenterol Motil; 2014 Jan; 26(1):21-7. PubMed ID: 24106924 [TBL] [Abstract][Full Text] [Related]
4. Effects of prucalopride on colonic transit, anorectal function and bowel habits in patients with chronic constipation. Sloots CE; Poen AC; Kerstens R; Stevens M; De Pauw M; Van Oene JC; Meuwissen SG; Felt-Bersma RJ Aliment Pharmacol Ther; 2002 Apr; 16(4):759-67. PubMed ID: 11929394 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of Prucalopride in Chronic Constipation: An Integrated Analysis of Six Randomized, Controlled Clinical Trials. Camilleri M; Piessevaux H; Yiannakou Y; Tack J; Kerstens R; Quigley EMM; Ke M; Da Silva S; Levine A Dig Dis Sci; 2016 Aug; 61(8):2357-2372. PubMed ID: 27056037 [TBL] [Abstract][Full Text] [Related]
6. Prucalopride, a systemic enterokinetic, for the treatment of constipation. Emmanuel AV; Roy AJ; Nicholls TJ; Kamm MA Aliment Pharmacol Ther; 2002 Jul; 16(7):1347-56. PubMed ID: 12144586 [TBL] [Abstract][Full Text] [Related]
7. Prucalopride is effective in patients with severe chronic constipation in whom laxatives fail to provide adequate relief. Results of a double-blind, placebo-controlled clinical trial. Coremans G; Kerstens R; De Pauw M; Stevens M Digestion; 2003; 67(1-2):82-9. PubMed ID: 12743445 [TBL] [Abstract][Full Text] [Related]
8. Prucalopride succinate for the treatment of constipation: an update. Bassotti G; Gambaccini D; Bellini M Expert Rev Gastroenterol Hepatol; 2016; 10(3):291-300. PubMed ID: 26647167 [TBL] [Abstract][Full Text] [Related]
9. A randomized trial of 5-hydroxytryptamine4-receptor agonist, YKP10811, on colonic transit and bowel function in functional constipation. Shin A; Acosta A; Camilleri M; Boldingh A; Burton D; Ryks M; Rhoten D; Zinsmeister AR Clin Gastroenterol Hepatol; 2015 Apr; 13(4):701-8.e1. PubMed ID: 25148765 [TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind, placebo-controlled, phase 3 trial to evaluate the efficacy, safety, and tolerability of prucalopride in men with chronic constipation. Yiannakou Y; Piessevaux H; Bouchoucha M; Schiefke I; Filip R; Gabalec L; Dina I; Stephenson D; Kerstens R; Etherson K; Levine A Am J Gastroenterol; 2015 May; 110(5):741-8. PubMed ID: 25869393 [TBL] [Abstract][Full Text] [Related]
11. Use of prucalopride in adults with chronic idiopathic constipation. Vijayvargiya P; Camilleri M Expert Rev Clin Pharmacol; 2019 Jul; 12(7):579-589. PubMed ID: 31096799 [No Abstract] [Full Text] [Related]
12. Prucalopride induces high-amplitude propagating contractions in the colon of patients with chronic constipation: a randomized study. Miner PB; Camilleri M; Burton D; Achenbach H; Wan H; Dragone J; Mellgard B Neurogastroenterol Motil; 2016 Sep; 28(9):1341-8. PubMed ID: 27270968 [TBL] [Abstract][Full Text] [Related]
13. A placebo-controlled trial of prucalopride for severe chronic constipation. Camilleri M; Kerstens R; Rykx A; Vandeplassche L N Engl J Med; 2008 May; 358(22):2344-54. PubMed ID: 18509121 [TBL] [Abstract][Full Text] [Related]
14. Prucalopride: a review of its use in the management of chronic constipation. Keating GM Drugs; 2013 Nov; 73(17):1935-50. PubMed ID: 24194435 [TBL] [Abstract][Full Text] [Related]
15. Faecal retention: a common cause in functional bowel disorders, appendicitis and haemorrhoids--with medical and surgical therapy. Raahave D Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748875 [TBL] [Abstract][Full Text] [Related]
16. Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives. Tack J; van Outryve M; Beyens G; Kerstens R; Vandeplassche L Gut; 2009 Mar; 58(3):357-65. PubMed ID: 18987031 [TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, and tolerability of long-term treatment with prucalopride. Piessevaux H; Corazziari E; Rey E; Simren M; Wiechowska-Kozlowska A; Kerstens R; Cools M; Barrett K; Levine A Neurogastroenterol Motil; 2015 Jun; 27(6):805-15. PubMed ID: 25808103 [TBL] [Abstract][Full Text] [Related]